Source: European Biotechnology

Followers on Owler

477

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Carsten Linnemann

CEO Approval Rating

86/100

Neogene is a New York-based biotechnology company that researches and develops T cell-based therapeutics for the treatment of cancer.

Neogene: Amsterdam Neogene Therapeutics Aquired by AstraZeneca